BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37730974)

  • 1. Novel iodoquinazolinones bearing sulfonamide moiety as potential antioxidants and neuroprotectors.
    Soliman AM; Ghorab WM; Lotfy DM; Karam HM; Ghorab MM; Ramadan LA
    Sci Rep; 2023 Sep; 13(1):15546. PubMed ID: 37730974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-κB/ PON1 pathway.
    Soliman AM; Karam HM; Mekkawy MH; Ghorab MM
    Eur J Med Chem; 2020 Jul; 197():112333. PubMed ID: 32361176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moiety.
    Soliman AM; Karam HM; Mekkawy MH; Higgins M; Dinkova-Kostova AT; Ghorab MM
    Eur J Med Chem; 2020 Aug; 200():112467. PubMed ID: 32502866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stress.
    Soliman AM; Mekkawy MH; Karam HM; Higgins M; Dinkova-Kostova AT; Ghorab MM
    Bioorg Med Chem Lett; 2021 Jun; 42():128002. PubMed ID: 33811990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Biological Evaluation and Docking Study of Mono- and Di-Sulfonamide Derivatives as Antioxidant Agents and Acetylcholinesterase Inhibitors.
    Güngör SA; Şahin İ; Güngör Ö; Tok TT; Köse M
    Chem Biodivers; 2022 Oct; 19(10):e202200325. PubMed ID: 35984664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide derivatives as anticancer and radiosensitizing agents.
    Soliman AM; Ghorab MM
    Bioorg Chem; 2019 Jul; 88():102956. PubMed ID: 31054432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory.
    Shrivastava SK; Srivastava P; Upendra TVR; Tripathi PN; Sinha SK
    Bioorg Med Chem; 2017 Feb; 25(4):1471-1480. PubMed ID: 28126439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
    Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biguanide-sulfonamide derivatives: synthesis, characterization and investigation of anticholinesterase inhibitory, antioxidant and DNA/BSA binding properties.
    Gungor O; Kose M
    J Biomol Struct Dyn; 2023; 41(24):14952-14967. PubMed ID: 36858484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
    Mohamed HS; Abdelgawad MA; Hegab M; Hamza ZS; Nagdy AM; Ahmed SA; Ahmed OM; Ghoneim MM
    Curr Org Synth; 2023; 20(3):339-350. PubMed ID: 36214306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of new chromone-derived aminophosphonates as potential acetylcholinesterase inhibitor.
    Shaikh S; Dhavan P; Ramana MMV; Jadhav BL
    Mol Divers; 2021 May; 25(2):811-825. PubMed ID: 32124162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of spatial memory in 5xFAD mice by targeting cholinesterases, oxidative stress and inflammatory signaling using 2-(hydroxyl-(2-nitrophenyl)methyl)cyclopentanone.
    Ullah R; Ali G; Subhan F; Khan A; Ahsan Halim S; Naveed M; Kalsoom S; Al-Harrasi A
    Int Immunopharmacol; 2021 Nov; 100():108083. PubMed ID: 34478946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors.
    Sonmez F; Zengin Kurt B; Gazioglu I; Basile L; Dag A; Cappello V; Ginex T; Kucukislamoglu M; Guccione S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):285-297. PubMed ID: 28097911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of aminothiazole derivatives as potential anti-Alzheimer's candidates.
    Soni A; Kumar A; Kumar V; Rawat R; Eyupoglu V
    Future Med Chem; 2024 Mar; 16(6):513-529. PubMed ID: 38375588
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.
    Eissa KI; Kamel MM; Mohamed LW; Doghish AS; Alnajjar R; Al-Karmalawy AA; Kassab AE
    Drug Dev Res; 2023 Aug; 84(5):937-961. PubMed ID: 37067008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.